Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382450440> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W4382450440 endingPage "513" @default.
- W4382450440 startingPage "508" @default.
- W4382450440 abstract "Aim: Determination of plasma concentrations of some polyunsaturated fatty acids and plasma omega 3/omega 6 ratios in patients with chronic kidney disease (CKD) on dialysis. Methods: The study was conducted on 188 people, from 18 to 70 years old, including 64 CKD patients on dialysis (study group), 60 CKD patients with conservative treatment (disease control group) and 64 normal healthy people (healthy control group). The concentration of unsaturated fatty acids was measured by gas chromatography-mass spectrometry. Total cholesterol, triglycerides, HDL-C, LDL-C, Total protein, albumin, CRP, urea, glucose, creatinine in plasma were measured by photometric methods. Results: The plasma saturated fatty acids of the three groups were roughly equivalent. The omega 3 Arachidonic acid (AA), Eicosapentaenoic acid (EPA), Docosahexaenoic acid (DHA) decreased in the study group compared with the other groups (p<0.05), EPA levels and DHA of the disease control group was lower than that of the healthy control group (p<0.05), there was no difference in ALA concentration between these two groups (p>0.05). Omega 6 such as Linoleic acid (LA), Arachidonic acid (AA) decreased, the lowest in the group 1, the highest in the group 3 (p<0.05). The ratio of omega 3/omega 6 (ω3/ω6) and total polyunsaturated fatty acids/ω6 decreased in groups 1 and 2 compared with group 3 (p<0.05). The group of patients with dialysis time less than 60 months had higher plasma omega concentration than the group with dialysis time over 60 months (p<0.05). Conclusion: The concentration of ω3 and ω6 and the ratio of ω3/ω6 in CKD patients on dialysis decreased compared with the group of CKD patients on conservative treatment and the healthy control group. The longer the dialysis time, the lower the concentration of unsaturated fatty acids. This confirms that the supplementation of unsaturated fatty acids for patients with chronic kidney disease on dialysis is necessary." @default.
- W4382450440 created "2023-06-29" @default.
- W4382450440 creator A5068029030 @default.
- W4382450440 date "2022-12-19" @default.
- W4382450440 modified "2023-09-26" @default.
- W4382450440 title "Plasma Polyunsaturated Fatty Acid Levels in Patients with Chronic Kidney Disease on Dialysis" @default.
- W4382450440 doi "https://doi.org/10.34297/ajbsr.2022.17.002388" @default.
- W4382450440 hasPublicationYear "2022" @default.
- W4382450440 type Work @default.
- W4382450440 citedByCount "0" @default.
- W4382450440 crossrefType "journal-article" @default.
- W4382450440 hasAuthorship W4382450440A5068029030 @default.
- W4382450440 hasBestOaLocation W43824504401 @default.
- W4382450440 hasConcept C126322002 @default.
- W4382450440 hasConcept C134018914 @default.
- W4382450440 hasConcept C181199279 @default.
- W4382450440 hasConcept C185592680 @default.
- W4382450440 hasConcept C19038510 @default.
- W4382450440 hasConcept C2776091944 @default.
- W4382450440 hasConcept C2776125364 @default.
- W4382450440 hasConcept C2777171753 @default.
- W4382450440 hasConcept C2778078955 @default.
- W4382450440 hasConcept C2778653478 @default.
- W4382450440 hasConcept C2779978075 @default.
- W4382450440 hasConcept C2780306776 @default.
- W4382450440 hasConcept C2780809830 @default.
- W4382450440 hasConcept C543025807 @default.
- W4382450440 hasConcept C55493867 @default.
- W4382450440 hasConcept C71924100 @default.
- W4382450440 hasConcept C90924648 @default.
- W4382450440 hasConceptScore W4382450440C126322002 @default.
- W4382450440 hasConceptScore W4382450440C134018914 @default.
- W4382450440 hasConceptScore W4382450440C181199279 @default.
- W4382450440 hasConceptScore W4382450440C185592680 @default.
- W4382450440 hasConceptScore W4382450440C19038510 @default.
- W4382450440 hasConceptScore W4382450440C2776091944 @default.
- W4382450440 hasConceptScore W4382450440C2776125364 @default.
- W4382450440 hasConceptScore W4382450440C2777171753 @default.
- W4382450440 hasConceptScore W4382450440C2778078955 @default.
- W4382450440 hasConceptScore W4382450440C2778653478 @default.
- W4382450440 hasConceptScore W4382450440C2779978075 @default.
- W4382450440 hasConceptScore W4382450440C2780306776 @default.
- W4382450440 hasConceptScore W4382450440C2780809830 @default.
- W4382450440 hasConceptScore W4382450440C543025807 @default.
- W4382450440 hasConceptScore W4382450440C55493867 @default.
- W4382450440 hasConceptScore W4382450440C71924100 @default.
- W4382450440 hasConceptScore W4382450440C90924648 @default.
- W4382450440 hasIssue "5" @default.
- W4382450440 hasLocation W43824504401 @default.
- W4382450440 hasOpenAccess W4382450440 @default.
- W4382450440 hasPrimaryLocation W43824504401 @default.
- W4382450440 hasRelatedWork W1972283418 @default.
- W4382450440 hasRelatedWork W2039511351 @default.
- W4382450440 hasRelatedWork W2041492180 @default.
- W4382450440 hasRelatedWork W2053687970 @default.
- W4382450440 hasRelatedWork W2115229762 @default.
- W4382450440 hasRelatedWork W2357632917 @default.
- W4382450440 hasRelatedWork W3020879878 @default.
- W4382450440 hasRelatedWork W3137983521 @default.
- W4382450440 hasRelatedWork W3213364865 @default.
- W4382450440 hasRelatedWork W4378528143 @default.
- W4382450440 hasVolume "17" @default.
- W4382450440 isParatext "false" @default.
- W4382450440 isRetracted "false" @default.
- W4382450440 workType "article" @default.